<DOC>
	<DOC>NCT01448031</DOC>
	<brief_summary>This is a study to compare the bioavailability of Acetyl Salicylic Acid (ASA) between Esomeprazole and Aspirin after multiple dose administration.</brief_summary>
	<brief_title>A Healthy Female and Male Volunteers Aspirin Study</brief_title>
	<detailed_description>A Phase I, open-label, randomized, two way crossover pharmacokinetic study comparing the bioavailability of acetylsalicylic acid (ASA) after 5 days repeated once daily administration of a fixed dose combination capsule of ASA 81 mg/esomeprazole 20 mg and ASA 80 mg (European aspirin reference product).</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Healthy male and female subjects aged 20 to 50 years inclusive. Have a body body mass index (BMI) of 18.0 to 30.0 kg/m2 inclusive and weigh 50.0 to 100.0 kg inclusive. Females must be of nonchildbearing potential or be of childbearing potential but have a negative serum hCG pregnancy test during screening and on admission. History of any clinically significant disease or disorder which, in the opinion of the Investigator, may either put the subject at risk because of participation in the study. Any clinically significant abnormalities in clinical chemistry, haematology or urinalysis results as judged by the Investigator. History of alcohol abuse or excessive intake of alcohol as judged by the Investigator.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Acetyl Salicylic Acid</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>